Development Engineering

Students from around the U.S. and the world — coming from the fields of finance, electrical engineering, nursing, and beyond — make up the inaugural cohort of the three-semester professional master’s program in development engineering, a transdisciplinary field founded at UC Berkeley that creates technology interventions in accordance with and for individuals living in low-resource settings.

Language barriers, international communiques requiring Embassy review, and disaster workers who are 6,300 miles away — not to mention a global pandemic — were just some of the challenges addressed by UC Berkeley students working with the Moroccan Royal Armed Forces Search and Rescue Unit. This incredible experience was part of a popular class supported by the National Security Innovation Network (NSIN), in partnership with the Blum Center for Developing Economies.

In early April, the first cohort of accepted students in the Blum Center’s inaugural Masters of Development Engineering program (M.DevEng) heard from award-winning faculty, social entrepreneurs, and student researchers and innovators, and also toured labs, Blum Hall, and iconic Berkeley landmarks – all virtually – in anticipation of reuniting in person on campus this fall.

In this WSJ op-ed, Nobel prize-winning CRISPR co-inventor Jennifer Doudna describes UC Berkeley’s research response to the pandemic, including the creation of a new rapid, point-of-need COVID test developed with Blum Center Research Director and CellScope inventor Dan Fletcher.

NPR: The Togo government partnered with Blum faculty member & I-School associate professor Joshua Blumenstock to use satellite imagery and mobile phone data to find citizens most in need. “Mobile phone data can reveal a lot about income level,” says Blumenstock.”

A collaboration between Blum Center Research Director and bioengineering professor Dan Fletcher, Professor Jennifer Doudna of UC Berkeley’s Innovative Genomics Institute, and Dr. Melanie Ott of UCSF’s Gladstones Institutes is developing a CRISPR-Cas13a-based diagnostic to rapidly detect SARS-CoV-2 RNA.